UNHUnitedHealth Group demonstrates strong fundamental performance and positive long-term thematic alignment in the healthcare sector. While recent technical indicators suggest a short-term consolidation, the overall outlook remains favorable for investors seeking stability and growth.
UNH is well-positioned to benefit from demographic trends, increasing healthcare utilization, and the expansion of its diversified business segments (UnitedHealthcare, Optum).
UNH exhibits robust financial health with consistent revenue growth, strong profitability, and a manageable debt level. Its valuation metrics are generally in line with its growth prospects.
The stock has experienced a significant decline, trading below key moving averages. While some oscillators suggest potential oversold conditions, the immediate trend remains bearish.
| Factor | Score |
|---|---|
| Healthcare Sector Growth | 90 |
| Diversified Business Model | 92 |
| Innovation in Health Technology | 85 |
| Regulatory Landscape | 75 |
| Market Penetration | 83 |
| Factor | Score |
|---|---|
| Valuation | 85 |
| Profitability | 78 |
| Growth | 82 |
| Balance Sheet Health | 70 |
| Cash Flow | 88 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 50 |
| Volume Confirmation | 65 |
| Support & Resistance | 70 |
Consistent Earnings Surprises
UnitedHealth Group (UNH) has consistently beaten EPS estimates in the last 12 quarters, with an average surprise of 4.07%. This demonstrates strong operational execution and reliable earnings generation.
Attractive Forward P/E Ratio
The forward P/E ratio of 11.66 is significantly lower than its historical average and suggests that the stock may be undervalued relative to its future earnings potential.
Elevated Price-to-Sales Ratio
The trailing Price-to-Sales (P/S) ratio of 0.8, while seemingly low, needs to be considered in context of the industry and growth prospects. A higher P/S might suggest high market expectations.
Slowing Revenue Growth in Latest Quarter
Revenue growth in the latest quarterly report (e.g., Q1 2025 revenue $109.575 billion) shows a net margin of 5.7%, which is a decrease from the previous quarter's 6.0% (Q4 2024), signaling potential margin pressure.
June 2025
16
Ex-Dividend Date
June 2025
24
Next Dividend Date
July 2025
29
Next Earnings Date
H: $5.48
A: $4.49
L: $3.69
H: 115.06B
A: 111.59B
L: 109.21B
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
379.34 USD
The 39 analysts offering 1 year price forecasts for UNH have a max estimate of 626.00 and a min estimate of 270.00.